Literature DB >> 32771656

Transcriptome analysis of senecavirus A-infected cells: Type I interferon is a critical anti-viral factor.

Jing Wang1, Chunxiao Mou2, Minmin Wang3, Shuonan Pan4, Zhenhai Chen5.   

Abstract

Senecavirus A (SVA)-associated vesicular disease (SAVD) has extensively been present in the swine industry during the past years. The mechanisms of SVA-host interactions at the molecular level, subsequent to SVA infection, are unclear. We studied the gene expression profiles of LLC-PK1 cells, with or without SVA infection, for 6 h and 12 h using an RNA-seq technology. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were performed on differentially expressed genes (DEGs). Immune-related genes and pathways were significantly modified after SVA infection. To confirm the RNA-seq data, 28 important DEGs were selected for RT-qPCR assays. All DEGs exhibited expression patterns consistent with the RNA-seq results. Among them, type I IFNs (including IFN-α and IFN-β) showed the largest upregulation, followed by RSAD2, DDX58, MX1 and the 17 other DEGs. In contrary, ID2 and another 5 DEGs were down-regulated or unchanged. These results indicated that type I IFNs play a critical role in host immune responses against SVA infection at early stage, while other immune-regulated genes directly or indirectly participate in the host immune responses.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Gene expression profile; Innate immune; Senecavirus A; Type I IFN; Vesicular disease

Mesh:

Substances:

Year:  2020        PMID: 32771656     DOI: 10.1016/j.micpath.2020.104432

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  6 in total

1.  Comparative Proteomic Analysis Reveals Mx1 Inhibits Senecavirus A Replication in PK-15 Cells by Interacting with the Capsid Proteins VP1, VP2 and VP3.

Authors:  Hang Gao; Zhaoying Xiang; Xinna Ge; Lei Zhou; Jun Han; Xin Guo; Yanhong Chen; Yongning Zhang; Hanchun Yang
Journal:  Viruses       Date:  2022-04-21       Impact factor: 5.818

2.  Senecavirus A- and Non-Infected Cells at Early Stage of Infection: Comparative Metabolomic Profiles.

Authors:  Fuxiao Liu; Bo Ni; Rong Wei
Journal:  Front Cell Infect Microbiol       Date:  2022-01-07       Impact factor: 5.293

3.  Identification of a B-Cell Epitope in the VP3 Protein of Senecavirus A.

Authors:  Mi Chen; Lulu Chen; Jing Wang; Chunxiao Mou; Zhenhai Chen
Journal:  Viruses       Date:  2021-11-18       Impact factor: 5.048

Review 4.  Senecavirus A as an Oncolytic Virus: Prospects, Challenges and Development Directions.

Authors:  Dankun Luo; Haiwei Wang; Qiang Wang; Wenping Liang; Bo Liu; Dongbo Xue; Yang Yang; Biao Ma
Journal:  Front Oncol       Date:  2022-03-17       Impact factor: 6.244

5.  Transcriptome Analyses of Senecavirus A-Infected PK-15 Cells: RIG-I and IRF7 Are the Important Factors in Inducing Type III Interferons.

Authors:  Kenan Peng; Lishuang Deng; Jianfeng Wei; Jun Zhao; Huidan Deng; Qian Tao; Chaoyuan Jiang; Yubing Zeng; Fei Li; Rubo Zhang; Xiangang Sun; Zhiwen Xu; Ling Zhu
Journal:  Front Microbiol       Date:  2022-03-04       Impact factor: 5.640

6.  Comparative Proteomic Profiling: Cellular Metabolisms Are Mainly Affected in Senecavirus A-Inoculated Cells at an Early Stage of Infection.

Authors:  Fuxiao Liu; Bo Ni; Rong Wei
Journal:  Viruses       Date:  2021-05-31       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.